Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism
Authors not listed
National Eye Institute (NEI) · 2006
Abstract
This study will test whether a new non-invasive technique can quickly and precisely measure retinal metabolism (the amount of energy retinal cells use). The retina is the part of the eye that sends information to the brain.
Participants in current NEI studies who have age-related macular degeneration (AMD), diabetic retinopathy, or von Hippel-Landau disease may be eligible for this study. Healthy volunteers will participate as controls. Patients with AMD must be 60 years of age or older; those with VHL disease or diabetic retinopathy must be 18 or older.
Participants undergo the tests and procedures required in the NEI study in which they previously enrolled. In addition, for the current study, they undergo metabolic mapping. For this procedure, the subject's eyes are dilated, and different amounts of low-level light are shone into the eye to see how different cells respond with changes in metabolism. Measurements are taken while the subject breathes room air and while he or she breathes medical grade oxygen for about 1 minute. The entire procedure takes about 15 minutes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2006). A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism. <em>National Eye Institute (NEI)</em>. https://clinicaltrials.gov/study/NCT00385333
Vancouver
Anonymous. A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism. National Eye Institute (NEI). 2006.
BibTeX
@misc{anon2006ANovel,
title = {A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism},
author = {Anonymous},
journal = {National Eye Institute (NEI)},
year = {2006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
St. Erik Eye Hospital 2017
Open access · US-GOV
Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2007
Open access · US-GOV
Noninvasive Optical Imaging of the Effects of External Spectral Filters on Macular Autofluorescence in Pseudophakic Eyes
National Eye Institute (NEI) 2003
Open access · US-GOV
Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease
Prim. Prof. Dr. Oliver Findl, MBA 2018
Open access · US-GOV
Reading Analysis in Ophthalmologic Patients: a Pilot Study
National Eye Institute (NEI) 2011
Open access · US-GOV
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
Archives of Ophthalmology 2002
Open access · OA